As stated, OCT most likely. But in that we can sell in Japan but I wouldn't be so overly happy with this. Vitrolife have been disappointing at best. My Japan giddy sales coming has almost disappeared.
Really the Data is great news, we can move forward. Vitrolife can use it to show clinics in Japan, but likely they'll want it to be past by at least one regulator before we get Japanese Govt insurance coverage. Makes no sense as they don't need it to go through any regulations there to sell, but they still want it somewhere? Love the Japanese mentality sometimes, that's why I left in the end, it just got too frustrating to get things done.
Heranova will be a big one for us, we need them to invest. But the good news IMO is we are about 300% lower MC than we should be, so always room to move when the market likes something. Bovine results will also come out shortly for OX Stress.
MEM Price at posting:
0.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)